Sun Pharma Advanced Research Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2025 ,inter alia, to consider and approve the Unaudited ....
SPARC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SPARC has informed the stock exchanges that its Board of Directors will meet on Monday, November 10, 2025, to consider and approve the Unaudited Standalone and Consolidated Financial Results for the second quarter and half year ended September 30, 2025. The trading window for insiders has been closed since October 1, 2025 and will remain closed till 48 hours after the results are announced. The intimation is filed under SEBI Regulation 29 of the Listing Obligations and Disclosure Requirements Regulations, 2015.
This is a routine pre-results intimation and does not contain actual financial data. Investors should watch the scheduled November 10, 2025 board meeting for the Q2 FY26 earnings announcement, which could move the stock depending on the reported numbers. The closed trading window signals that results may be material.